Fox Jennifer A.insider trades
In SEC Form 4 filings, Fox Jennifer A. is listed as Director of Apogee Therapeutics, Inc. (APGE). Fox Jennifer A. reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Sep 3.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| APGEApogee Therapeutics, Inc. | Director | 4 | Sep 3 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-03
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| APGEApogee Therapeutics, Inc. | Sep 3 | Sep 3 | D | 34,824 | not reported | not reported | not reported | No | Form 4 |
| APGEApogee Therapeutics, Inc. | Sep 3 | Sep 3 | D · derivative | 10,370 | $43.85 | $454,725 | not reported | No | Form 4 |
| APGEApogee Therapeutics, Inc. | Sep 3 | Sep 3 | D · derivative | 14,461 | $41.66 | $602,445 | not reported | No | Form 4 |
| APGEApogee Therapeutics, Inc. | Sep 3 | Sep 3 | D · derivative | 7,657 | $85.00 | $650,845 | not reported | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.